PR Newswire
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Dec. 28, 2017
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C.,
Dec. 28, 2017 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today
that Martine Rothblatt, Ph.D., Chairman and Chief Executive Officer of United Therapeutics, will
provide an overview and update on the company's business at the 36th Annual J.P. Morgan Healthcare Conference in
San Francisco, California.
The presentation and the immediately following Q&A session will take place on Monday, January 8,
2018, at 1:30 PM Pacific Standard Time, and can be accessed via a live webcast on the United
Therapeutics website at http://www.unither.com under the "Investors" tab in
the "Events and Presentations" section. An archived, recorded version of the presentation and the Q&A session will be
available approximately twenty-four hours after the Q&A session ends and can be accessed at the same location for 90 days.
[uthr-g]
About United Therapeutics
United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of innovative
products to address the unmet medical needs of patients with chronic and life-threatening conditions.
View original content:http://www.prnewswire.com/news-releases/united-therapeutics-corporation-to-present-at-36th-annual-jp-morgan-healthcare-conference-300575499.html
SOURCE United Therapeutics Corporation